Solara Active Pharma Sciences Ltd (SOLARA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003017,
    "name": "Solara Active",
    "stock_name": "Solara Active",
    "full_name": "Solara Active Pharma Sciences Ltd",
    "name_url": "stocks-analysis/solara-active",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "510.20",
    "chg": -2.7,
    "chgp": "-0.53%",
    "dir": -1,
    "prev_price": "512.90",
    "mcapval": "2,438.36 Cr",
    "mcap": "Small Cap",
    "scripcode": 541540,
    "symbol": "SOLARA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE624Z01016",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "1.36 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/solara-active-1003017-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Solara Active Pharma Sciences consolidated net profit rises 55.04% in the June 2026 quarter",
        "link": "https://news.google.com/rss/articles/CBMihwJBVV95cUxQU2JoQTJfRFZoZ2l1aVVyenNGTjR6WjdrUms5VDkycUFFYnJOWmxjcTFKZ3FxM1hvajE4ek1Ud051ekRLc1Z4RnlBT3NfcXFjTUp1STU5RDhDQ2lMTi1DbWJacm1CMVhXUVdmNWFSLTNFUEdMb0JfbkY0WEZ5anJlbEdWX2FYeGVSZjlveHItTE1KeEtIRnNqTVRvREdseS1ucEdNWnUwdDVyYlluNVU1c2N6c3c0cTQ5Z21yWHROOHg0M3pZcERUT2xSd0liNkVpVmYxVjh1U1kyZXI5NkktYVFoRlNydDRzQ0pCU0tza3J1Tkl5b3dWcldOWno2Z1pMRFhuVUdaQdIBhwJBVV95cUxQU2JoQTJfRFZoZ2l1aVVyenNGTjR6WjdrUms5VDkycUFFYnJOWmxjcTFKZ3FxM1hvajE4ek1Ud051ekRLc1Z4RnlBT3NfcXFjTUp1STU5RDhDQ2lMTi1DbWJacm1CMVhXUVdmNWFSLTNFUEdMb0JfbkY0WEZ5anJlbEdWX2FYeGVSZjlveHItTE1KeEtIRnNqTVRvREdseS1ucEdNWnUwdDVyYlluNVU1c2N6c3c0cTQ5Z21yWHROOHg0M3pZcERUT2xSd0liNkVpVmYxVjh1U1kyZXI5NkktYVFoRlNydDRzQ0pCU0tza3J1Tkl5b3dWcldOWno2Z1pMRFhuVUdaQQ?oc=5",
        "imagepath": "",
        "date": "2026-07-23 14:16:17",
        "description": "Solara Active Pharma Sciences consolidated net profit rises 55.04% in the June 2026 quarter  Business Standard..."
      },
      {
        "title": "Crisil Ratings upgrades ratings of Solara Active Pharma to \\'BBB+/A2\\'",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-24 13:17:23",
        "description": "Crisil Ratings upgrades ratings of Solara Active Pharma to \\'BBB+/A2\\'  Business Standard..."
      }
    ],
    "total": 2,
    "sid": "1003017",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/solara-active-pharma-sciences-1003017"
  },
  "announcements": [
    {
      "caption": "Update With Respect To Our Intimation Dated July 23 2026 Regarding Appointment Of CIO And SMP Of The Company.",
      "datetime": "07-Aug-2026",
      "details": "Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23 2026 regarding appointment of Chief Information Officer (\"CIO\") and Senior Management Personnel (\"SMP\")",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "29-Jul-2026",
      "details": "Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "24-Jul-2026",
      "details": "Solara Active Pharma Sciences Limited has informed the exchange about the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has declared <strong>30%</strong> dividend, ex-date: 18 Aug 21",
          "dt": "2021-08-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has announced <strong>1:3</strong> rights issue, ex-date: 15 May 24",
          "dt": "2024-05-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
News and Views